Patents by Inventor Priti Vaidyanathan

Priti Vaidyanathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof
    Patent number: 10172903
    Abstract: Disclosed are methods of managing hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract of Cyperus rotundus rhizomes standardized to contain 5% of total stilbenes.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: January 8, 2019
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Douglas Kalman, Beena Bhat, Priti Vaidyanathan, Sarang Bani, Anjali Pandey, Suresh Karri
  • Composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof
    Patent number: 9782450
    Abstract: Disclosed are methods of managing obesity and hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract of Cyperus rotundus rhizomes standardized to contain 5% of total stilbenes.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: October 10, 2017
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Douglas Kalman, Beena Bhat, Priti Vaidyanathan, Sarang Bani, Anjali Pandey, Suresh Karri
  • COMPOSITION COMPRISING SCIRPUSIN A AND SCIRPUSIN B AND ANTI-OBESITY POTENTIAL THEREOF
    Publication number: 20170072003
    Abstract: Disclosed are methods of managing hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract of Cyperus rotundus rhizomes standardized to contain 5% of total stilbenes.
    Type: Application
    Filed: July 19, 2016
    Publication date: March 16, 2017
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Douglas Kalman, Beena Bhat, Priti Vaidyanathan, Sarang Bani, Anjali Pandey, Suresh Karri
  • Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using SBC-37-01, MTCC 5856
    Patent number: 9579352
    Abstract: The present invention discloses a process for the therapeutic management of diarrhea predominant irritable bowel syndrome in humans comprising the oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing not less than 2 billion spores) along with standard treatment of care in a specific manner.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: February 28, 2017
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Natarajan Sankaran, Priti Vaidyanathan, Sivakumar Arumugam, Suresh Kumar Karri
  • Composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof
    Patent number: 9387193
    Abstract: Disclosed is a composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof. Also disclosed are methods of inhibiting adipogenesis using a composition comprising scirpusin A and scirpusin B. The present invention also disclosed methods of therapeutically managing obesity in mammals using a composition comprising scirpusin A and scirpusin B. Still further, the present invention also relates to a method of obtaining compositions comprising A. scirpusin A and scirpusin B and B. piceatannol and its dimers scirpusin A and scirpusin B through bioactivity guided fractionation of the rhizomes of Cyperus rotundus.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: July 12, 2016
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Douglas Kalman, Beena Bhat, Priti Vaidyanathan, Sarang Bani, Anjali Pandey
  • Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC-37-01, MTCC 5856
    Publication number: 20160129054
    Abstract: The present invention discloses a process for the therapeutic management of diarrhea predominant irritable bowel syndrome in humans comprising the oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing not less than 2 billion spores) along with standard treatment of care in a specific manner.
    Type: Application
    Filed: November 10, 2014
    Publication date: May 12, 2016
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Natarajan Sankaran, Priti Vaidyanathan, Sivakumar Arumugam, Suresh Kumar Karri
  • COMPOSITION COMPRISING SCIRPUSIN A AND SCIRPUSIN B AND ANTI-OBESITY POTENTIAL THEREOF
    Publication number: 20150238438
    Abstract: Disclosed are methods of managing obesity and hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract of Cyperus rotundus rhizomes standardized to contain 5% of total stiibenes.
    Type: Application
    Filed: May 6, 2015
    Publication date: August 27, 2015
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Douglas Kalman, Beena Bhat, Priti Vaidyanathan, Sarang Bani, Anjali Pandey, Suresh Karri